We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000998:SSEYuan Long Ping High-Tech Agriculture Co., Ltd. Analysis

Data as of 2026-03-12 - not real-time

CN¥10.58

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Yuan Long Ping trades at CNY10.58, comfortably above its 20‑day SMA (10.14) and 50‑day SMA (9.84), indicating short‑term price strength. The RSI sits at 59.8, well below overbought levels, while the MACD histogram is positive (0.04) and the signal line is bullish, supporting a modest upside bias. Volume has been rising, and the stock is trading near the technical resistance of CNY11.16 after bouncing off support at CNY9.68. However, the 30‑day volatility is high at roughly 40 % and beta is near zero, suggesting the moves are driven more by company‑specific factors than market swings. On the fundamentals side, revenue has more than doubled (125 % growth) but operating margin is a deep –47 % and net profit margin is negative, resulting in a trailing EPS of –0.02. The forward EPS of 0.5 points to a potential earnings rebound, yet the balance sheet is strained with a debt‑to‑equity ratio of 108 % and total debt exceeding cash by over CNY6 bn.
The DCF‑derived fair value is only CNY6.02, implying the market price is roughly 16 % above intrinsic estimates, and the forward P/E of 21.2 is modestly high for a loss‑making firm. Dividend yield is a meager 0.38 % and the payout ratio of 166 % is unsustainable given current earnings. The company operates in China’s consumer‑defensive farm‑products segment, which benefits from stable food demand but is exposed to policy and regulatory shifts. Overall, the stock presents a mixed picture: technical indicators are mildly bullish, yet valuation is stretched and financial health remains weak. Investors should weigh the short‑term upside against the long‑term risks of high leverage and ongoing losses. A cautious stance—monitoring earnings recovery and debt reduction—appears prudent.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD and price above short‑term SMAs
  • Increasing volume supporting momentum
  • Proximity to technical resistance and overvaluation

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Forward EPS improvement suggests earnings recovery
  • High debt‑to‑equity ratio limits flexibility
  • Valuation still above DCF fair value

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained negative operating margins and weak cash conversion
  • Debt burden exceeds cash reserves
  • Dividend payout unsustainable and growth prospects uncertain

Key Metrics & Analysis

Financial Health

Revenue Growth125.70%
Profit Margin-0.87%
P/E Ratio21.2
ROE-1.92%
ROA0.57%
Debt/Equity107.79
P/B Ratio2.7
Op. Cash FlowCN¥1.6B
Free Cash FlowCN¥410.8M

Technical Analysis

TrendNeutral
RSI59.8
SupportCN¥9.68
ResistanceCN¥11.16
MA 20CN¥10.14
MA 50CN¥9.84
MA 200CN¥9.87
MACDBullish
VolumeIncreasing
Fear & Greed Index76.11

Valuation

Fair ValueCN¥6.02
Target PriceCN¥12.26
Upside/Downside15.85%
GradeOvervalued
TypeBlend
Dividend Yield0.38%

Risk Assessment

Beta0.00
Volatility39.59%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.